|
Block b3: estimated date of event is based on the article published date.Block e1: the initial reporter facility name is (b)(6).Block d4, h4: the suspect device lot number and upn were not reported.Therefore, the manufacture and expiration dates are unknown.Block h6: imdrf patient code e1021 captures the reportable event of pancreatitis.Imdrf patient code e1109 captures the reportable event of cholangitis.Imdrf patient code e0506 captures the reportable event of gastro-intestinal bleeding.Imdrf patient code e2330 captures the reportable event of post-procedural pain.Imdrf patient code e2326 captures the reportable event of cholecystitis.
|
|
Boston scientific became aware of an event involving rx cytology brushes through the article, comparison of two intraductal brush cytology devices for suspected malignant biliary strictures: randomized controlled trial, by myrte gorris, et al.Per the article, between june 2016 and june 2021, rx cytology brushes were used in endoscopic retrograde cholangiopancreatography (ercp) procedures during a randomized controlled trial.Procedure-related adverse events mentioned in the article included pancreatitis, gastro-intestinal bleeding, cholangitis, cholecystitis, and post-procedural pain.Please see the referenced article for full details.
|